SAM treatment induces DNA hypermethylation at the promoter of vascular endothelial growth factor-C (VEGF-C) and subsequently reduces VEGF-C expression, which inhibits gastric cancer cell growth and tumorigenesis (Da et al., 2014). This evidence concerns the gene VEGFC and gastric cancer.